Muneer A Satter Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Muneer A Satter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Muneer A Satter. Muneer A Satter is Director in VITAL THERAPIES INC ($VTL) and 10% Owner in AILERON THERAPEUTICS INC ($ALRN) and Director in AILERON THERAPEUTICS INC ($ALRN) and See Remarks in AILERON THERAPEUTICS INC ($ALRN) and Director in Aerpio Pharmaceuticals, Inc. ($ZETAII) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA) and Director in Annexon, Inc. ($ANNX).
Latest Insider Trading Transactions of Muneer A Satter
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARPO, ALRN, AKBA, ANNX, VTL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | A | 21.03 | 10,000 | 210,300 | 10,000 | |
| Jan 08 2021 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | See Remarks | Buy | P | 1.10 | 9,000,000 | 9,900,000 | 16,609,449 | 7.6 M to 16.6 M (+118.27 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 2,812,543 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 5,537,036 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 4,016,573 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Option Exercise | C | 0.00 | 3,095,238 | 0 | 0 | |
| Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Buy | P | 17.00 | 200,000 | 3,400,000 | 1,954,978 | 1.8 M to 2 M (+11.40 %) |
| Jul 28 2020 | ANNX | Annexon, Inc. | Satter Muneer A | Director | Buy | C | 0.00 | 1,754,978 | 0 | 1,754,978 | 0 to 1.8 M |
| Jun 09 2020 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | Director | Buy | P | 1.10 | 3,700,000 | 4,070,000 | 7,609,449 | 3.9 M to 7.6 M (+94.64 %) |
| Jun 19 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Option Exercise | A | 0.96 | 21,400 | 20,544 | 21,400 | |
| Jan 10 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.45 | 23,818 | 58,442 | 5,621,835 | 5.6 M to 5.6 M (+0.43 %) |
| Jan 10 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.39 | 20,000 | 47,876 | 5,598,017 | 5.6 M to 5.6 M (+0.36 %) |
| Jan 10 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.20 | 20,000 | 43,972 | 5,578,017 | 5.6 M to 5.6 M (+0.36 %) |
| Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.18 | 20,000 | 43,558 | 5,558,017 | 5.5 M to 5.6 M (+0.36 %) |
| Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.18 | 20,000 | 43,558 | 5,558,017 | 5.5 M to 5.6 M (+0.36 %) |
| Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.12 | 20,000 | 42,396 | 5,538,017 | 5.5 M to 5.5 M (+0.36 %) |
| Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.12 | 20,000 | 42,396 | 5,538,017 | 5.5 M to 5.5 M (+0.36 %) |
| Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.08 | 20,000 | 41,508 | 5,518,017 | 5.5 M to 5.5 M (+0.36 %) |
| Jan 07 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.08 | 20,000 | 41,508 | 5,518,017 | 5.5 M to 5.5 M (+0.36 %) |
| Jan 02 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.94 | 20,000 | 38,838 | 5,498,017 | 5.5 M to 5.5 M (+0.37 %) |
| Jan 02 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.75 | 20,000 | 34,900 | 5,478,017 | 5.5 M to 5.5 M (+0.37 %) |
| Jan 02 2019 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.72 | 20,000 | 34,372 | 5,458,017 | 5.4 M to 5.5 M (+0.37 %) |
| Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.67 | 20,000 | 33,410 | 5,438,017 | 5.4 M to 5.4 M (+0.37 %) |
| Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.69 | 20,000 | 33,854 | 5,418,017 | 5.4 M to 5.4 M (+0.37 %) |
| Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.84 | 20,000 | 36,870 | 5,398,017 | 5.4 M to 5.4 M (+0.37 %) |
| Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.67 | 20,000 | 33,410 | 5,438,017 | 5.4 M to 5.4 M (+0.37 %) |
| Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.69 | 20,000 | 33,854 | 5,418,017 | 5.4 M to 5.4 M (+0.37 %) |
| Dec 27 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.84 | 20,000 | 36,870 | 5,398,017 | 5.4 M to 5.4 M (+0.37 %) |
| Dec 20 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.85 | 20,000 | 36,984 | 5,378,017 | 5.4 M to 5.4 M (+0.37 %) |
| Dec 20 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.92 | 20,000 | 38,384 | 5,358,017 | 5.3 M to 5.4 M (+0.37 %) |
| Dec 20 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.99 | 20,000 | 39,856 | 5,338,017 | 5.3 M to 5.3 M (+0.38 %) |
| Dec 14 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.00 | 20,000 | 40,094 | 5,318,017 | 5.3 M to 5.3 M (+0.38 %) |
| Dec 14 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.02 | 20,000 | 40,308 | 5,298,017 | 5.3 M to 5.3 M (+0.38 %) |
| Dec 14 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.05 | 20,000 | 40,938 | 5,278,017 | 5.3 M to 5.3 M (+0.38 %) |
| Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.09 | 20,000 | 41,846 | 5,258,017 | 5.2 M to 5.3 M (+0.38 %) |
| Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.09 | 20,000 | 41,846 | 5,258,017 | 5.2 M to 5.3 M (+0.38 %) |
| Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.13 | 20,000 | 42,608 | 5,238,017 | 5.2 M to 5.2 M (+0.38 %) |
| Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.13 | 20,000 | 42,608 | 5,238,017 | 5.2 M to 5.2 M (+0.38 %) |
| Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.14 | 20,000 | 42,788 | 5,218,017 | 5.2 M to 5.2 M (+0.38 %) |
| Dec 11 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.14 | 20,000 | 42,788 | 5,218,017 | 5.2 M to 5.2 M (+0.38 %) |
| Dec 06 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.18 | 20,000 | 43,584 | 5,198,017 | 5.2 M to 5.2 M (+0.39 %) |
| Dec 06 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.10 | 20,000 | 41,994 | 5,178,017 | 5.2 M to 5.2 M (+0.39 %) |
| Dec 06 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.99 | 20,000 | 39,774 | 5,158,017 | 5.1 M to 5.2 M (+0.39 %) |
| Nov 30 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.98 | 20,000 | 39,692 | 5,138,017 | 5.1 M to 5.1 M (+0.39 %) |
| Nov 30 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 2.01 | 20,000 | 40,118 | 5,118,017 | 5.1 M to 5.1 M (+0.39 %) |
| Nov 30 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 1.94 | 20,000 | 38,714 | 5,098,017 | 5.1 M to 5.1 M (+0.39 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Sell | S | 0.29 | 7,044,777 | 2,054,257 | 0 | 7 M to 0 (-100.00 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Sell | S | 0.36 | 447,500 | 160,384 | 7,044,777 | 7.5 M to 7 M (-5.97 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Sell | S | 0.50 | 3,890,000 | 1,930,996 | 7,492,277 | 11.4 M to 7.5 M (-34.18 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Sell | S | 0.29 | 7,044,777 | 2,054,257 | 0 | 7 M to 0 (-100.00 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Sell | S | 0.36 | 447,500 | 160,384 | 7,044,777 | 7.5 M to 7 M (-5.97 %) |
| Sep 17 2018 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Sell | S | 0.50 | 3,890,000 | 1,930,996 | 7,492,277 | 11.4 M to 7.5 M (-34.18 %) |
| Jun 29 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 3.85 | 1,818,182 | 7,000,001 | 5,078,017 | 3.3 M to 5.1 M (+55.78 %) |
| Jun 22 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Option Exercise | A | 4.00 | 21,400 | 85,600 | 21,400 | |
| Jun 15 2018 | AKBA | Akebia Therapeutic ... | Satter Muneer A | Option Exercise | A | 11.14 | 12,500 | 139,250 | 12,500 | ||
| May 25 2018 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Option Exercise | A | 6.10 | 29,538 | 180,182 | 29,538 | |
| Mar 23 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 5.00 | 1,000 | 5,000 | 3,259,835 | 3.3 M to 3.3 M (+0.03 %) |
| Mar 23 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 4.85 | 4,000 | 19,390 | 3,258,835 | 3.3 M to 3.3 M (+0.12 %) |
| Mar 21 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 4.97 | 5,400 | 26,860 | 3,254,835 | 3.2 M to 3.3 M (+0.17 %) |
| Mar 21 2018 | ARPO | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 4.96 | 7,600 | 37,725 | 3,249,435 | 3.2 M to 3.2 M (+0.23 %) |
| Dec 14 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 5.57 | 50,000 | 278,570 | 11,382,277 | 11.3 M to 11.4 M (+0.44 %) |
| Dec 14 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 5.40 | 50,000 | 269,765 | 11,332,277 | 11.3 M to 11.3 M (+0.44 %) |
| Dec 11 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 4.96 | 50,000 | 248,225 | 11,282,277 | 11.2 M to 11.3 M (+0.45 %) |
| Dec 11 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 4.92 | 50,000 | 246,185 | 11,232,277 | 11.2 M to 11.2 M (+0.45 %) |
| Dec 11 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 4.77 | 50,000 | 238,730 | 11,182,277 | 11.1 M to 11.2 M (+0.45 %) |
| Sep 14 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 4.25 | 30,000 | 127,539 | 11,132,277 | 11.1 M to 11.1 M (+0.27 %) |
| Sep 14 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 4.13 | 50,000 | 206,465 | 11,102,277 | 11.1 M to 11.1 M (+0.45 %) |
| Sep 14 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.74 | 50,000 | 187,225 | 11,052,277 | 11 M to 11.1 M (+0.45 %) |
| Sep 12 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.53 | 50,000 | 176,615 | 11,002,277 | 11 M to 11 M (+0.46 %) |
| Jul 11 2017 | AKBA | Akebia Therapeutic ... | Satter Muneer A | Director | Buy | P | 14.50 | 1,034,482 | 14,999,989 | 3,037,042 | 2 M to 3 M (+51.66 %) |
| Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 247,398 | 0 | 0 | |
| Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 159,548 | 0 | 0 | |
| Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 183,944 | 0 | 0 | |
| Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | 10% Owner | Option Exercise | C | 0.00 | 847,721 | 0 | 0 | |
| Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | 10% Owner | Buy | P | 15.00 | 33,333 | 499,995 | 178,106 | 144.8 K to 178.1 K (+23.02 %) |
| Jul 06 2017 | ALRN | AILERON THERAPEUTI ... | Satter Muneer A | 10% Owner | Buy | C | 0.00 | 144,773 | 0 | 144,773 | 0 to 144.8 K |
| Jun 19 2017 | AKBA | Akebia Therapeutic ... | Satter Muneer A | Option Exercise | A | 14.37 | 12,500 | 179,625 | 12,500 | ||
| Jun 14 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.10 | 10,000 | 31,008 | 10,952,277 | 10.9 M to 11 M (+0.09 %) |
| Jun 14 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.03 | 10,000 | 30,311 | 10,942,277 | 10.9 M to 10.9 M (+0.09 %) |
| Jun 12 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.06 | 10,000 | 30,615 | 10,932,277 | 10.9 M to 10.9 M (+0.09 %) |
| Jun 12 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.17 | 10,000 | 31,733 | 10,922,277 | 10.9 M to 10.9 M (+0.09 %) |
| Jun 12 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.10 | 10,000 | 30,958 | 10,912,277 | 10.9 M to 10.9 M (+0.09 %) |
| Jun 07 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.21 | 10,000 | 32,074 | 10,902,277 | 10.9 M to 10.9 M (+0.09 %) |
| Jun 07 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 3.19 | 10,000 | 31,940 | 10,892,277 | 10.9 M to 10.9 M (+0.09 %) |
| May 25 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Option Exercise | A | 3.20 | 63,031 | 201,699 | 63,031 | |
| Mar 27 2017 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 4.00 | 3,750,000 | 15,000,000 | 10,882,277 | 7.1 M to 10.9 M (+52.58 %) |
| Mar 17 2017 | ZETAII | Aerpio Pharmaceuti ... | Satter Muneer A | Director | Buy | P | 5.00 | 1,120,000 | 5,600,000 | 3,241,835 | 2.1 M to 3.2 M (+52.78 %) |
| Jun 20 2016 | AKBA | Akebia Therapeutic ... | Satter Muneer A | Option Exercise | A | 8.56 | 12,500 | 107,000 | 12,500 | ||
| May 26 2016 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Option Exercise | A | 8.17 | 30,239 | 247,053 | 30,239 | |
| Oct 29 2015 | VTL | VITAL THERAPIES IN ... | Satter Muneer A | Director | Buy | P | 5.50 | 400,000 | 2,200,000 | 7,132,277 | 6.7 M to 7.1 M (+5.94 %) |
| Jun 12 2015 | AKBA | Akebia Therapeutic ... | Satter Muneer A | Director | Option Exercise | A | 7.86 | 5,000 | 39,300 | 5,000 | |
| Apr 22 2015 | AKBA | Akebia Therapeutic ... | Satter Muneer A | Director | Buy | P | 8.25 | 420,000 | 3,465,000 | 2,002,560 | 1.6 M to 2 M (+26.54 %) |
Page: 1